Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience.
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 3, p. 192, doi. 10.3857/roj.2022.00101
- By:
- Publication type:
- Article
Works matching IS 22341900 AND DT 2022 AND VI 40 AND IP 3
Results: 6
1
2
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer.
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 3, p. 200, doi. 10.3857/roj.2022.00339
- By:
- Publication type:
- Article
3
Mucoepidermoid carcinoma of the trachea in a 9-year-old male child: case report and review of literature.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
4
Dosimetric analysis of intracavitary brachytherapy applicators: a practical study.
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 3, p. 180, doi. 10.3857/roj.2022.00199
- By:
- Publication type:
- Article
5
Radiotherapy, volume reduction, and short-term surgical outcomes in the treatment of large myxoid liposarcomas.
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 3, p. 172, doi. 10.3857/roj.2022.00094
- By:
- Publication type:
- Article
6
Stereotactic body radiation therapy for pancreatic cancer: a potential ally in the era of immunotherapy?
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 3, p. 169, doi. 10.3857/roj.2022.00479
- By:
- Publication type:
- Article